GEJ

基本解釋

World Cup ali anhi manlailh gej itgej bna ve?
認(rèn)為世界杯冠軍是誰(shuí)？
This phase II study was designed to evaluate the activity and safety of a combination of irinotecan, docetaxel and oxaliplatin in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
本文進(jìn)行聯(lián)合依立替康、紫杉醇和奧沙利鉑治療轉(zhuǎn)移性胃腺癌和胃及食管連接部腺癌的臨床II期實(shí)驗(yàn)來(lái)評(píng)價(jià)療效和安全性。
This study describes the incidence and clinical course of patients with gastric or gastroesophageal junction (GEJ) carcinoma who experience a perforation while receiving chemotherapy.
本實(shí)驗(yàn)即描述胃癌或胃食管交界（GEJ）癌患者在接受化療過(guò)程中穿孔的的發(fā)生率和發(fā)病過(guò)程。
The prevalence of IM in LSBE,SSBE and GEJ is 26. 53% , 33.85% and 34.00% respectively;
A、B、C3組IM發(fā)生率分別為26.;53%25、33
Results : 1032 patients at MSKCC received systemic cytotoxic chemotherapy for locally advanced or metastatic gastric or GEJ carcinoma;
結(jié)果MSKCC的1032例局部進(jìn)展期或轉(zhuǎn)移的胃癌或者GEJ接受系統(tǒng)化療的患者進(jìn)入研究。